###begin article-title 0
Fiber Type-Specific Nitric Oxide Protects Oxidative Myofibers against Cachectic Stimuli
###end article-title 0
###begin p 1
Conceived and designed the experiments: JS Z. Yan Z. Yu PL. Performed the experiments: Z. Yu PL MZ. Analyzed the data: Z. Yan Z. Yu MZ. Contributed reagents/materials/analysis tools: Z. Yan MH. Wrote the paper: JS Z. Yan.
###end p 1
###begin p 2
###xml 576 592 576 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx)/atrogin-1</italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 942 946 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 1018 1033 1018 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 1090 1097 1090 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1191 1195 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
Oxidative skeletal muscles are more resistant than glycolytic muscles to cachexia caused by chronic heart failure and other chronic diseases. The molecular mechanism for the protection associated with oxidative phenotype remains elusive. We hypothesized that differences in reactive oxygen species (ROS) and nitric oxide (NO) determine the fiber type susceptibility. Here, we show that intraperitoneal injection of endotoxin (lipopolysaccharide, LPS) in mice resulted in higher level of ROS and greater expression of muscle-specific E3 ubiqitin ligases, muscle atrophy F-box (MAFbx)/atrogin-1 and muscle RING finger-1 (MuRF1), in glycolytic white vastus lateralis muscle than in oxidative soleus muscle. By contrast, NO production, inducible NO synthase (iNos) and antioxidant gene expression were greatly enhanced in oxidative, but not in glycolytic muscles, suggesting that NO mediates protection against muscle wasting. NO donors enhanced iNos and antioxidant gene expression and blocked cytokine/endotoxin-induced MAFbx/atrogin-1 expression in cultured myoblasts and in skeletal muscle in vivo. Our studies reveal a novel protective mechanism in oxidative myofibers mediated by enhanced iNos and antioxidant gene expression and suggest a significant value of enhanced NO signaling as a new therapeutic strategy for cachexia.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Bodine1">[1]</xref>
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Fielitz1">[7]</xref>
###xml 399 414 399 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 1036 1039 1036 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Shah1">[8]</xref>
###xml 1040 1044 1040 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Acharyya1">[13]</xref>
Chronic diseases are often associated with and exacerbated by loss of lean body mass known as cachexia mainly due to skeletal muscle wasting. Recent research efforts have led to the current understanding of the molecular and signaling mechanisms responsible for skeletal muscle atrophy under various pathological conditions [1]-[7]. In particular, enhanced expression of muscle-specific E3 ligases, MAFbx/atrogin-1 and MuRF1, with function in protein ubiquitination have been shown to mediate proteosome-dependent protein degradation in muscle wasting. Therefore, expression of these genes is now served as an early marker of skeletal muscle atrophy. Skeletal muscles of different fiber type composition have different contractile and metabolic properties. Oxidative muscles (predominantly type I and/or IIa fibers) are generally rich, while glycolytic muscles (predominantly type IId/x and/or IIb fibers) are poor, in mitochondria and capillaries. Interestingly, oxidative muscles are more resistant to atrophy than glycolytic muscles [8]-[13]; however, much remains unknown regarding the molecular mechanism(s) for the fiber type-specific muscle wasting. The "built-in" protection in oxidative myofibers provides an excellent experimental model to decipher the skeletal muscle wasting process and search for new drug target(s) to treat this detrimental symptom that affects the morbidity and mortality of many chronic diseases.
###end p 4
###begin p 5
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Muller1">[14]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Fagan1">[17]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Linke1">[18]</xref>
###xml 548 551 548 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li1">[6]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Bianca1">[19]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Appell1">[20]</xref>
ROS are well recognized to have primarily deleterious effects in mammalian cells. High level, sustained increase in ROS leads to oxidative cellular injury that plays "cause-effect" roles in the pathogenesis of chronic diseases and syndromes including cachexia. The deleterious role of ROS in muscle wasting has been shown in previous studies. Firstly, increased production of ROS [14]-[17] and reduced antioxidant gene expression [18] are associated with muscle catabolism. Secondly, exogenous ROS activate proteosome-dependent protein degradation [6]. Lastly, antioxidant treatment attenuates skeletal muscle atrophy [19], [20]. However, little is known about the fiber type differences of oxidative stress in skeletal muscle in cachexia.
###end p 5
###begin p 6
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Krolick1">[11]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Boveris1">[21]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Nin1">[25]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Boveris1">[21]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Nin1">[25]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Reid1">[27]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames1">[23]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Nin1">[25]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Krolick1">[11]</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Wang1">[28]</xref>
The functional role of nitric oxide (NO) and related oxides of nitrogen (reactive nitrogen species, RNS) in skeletal muscle wasting is controversial and far less well understood except that it is well known that NO synthase (NOS) expression is often increased in muscle wasting disorders [11], [21]-[25]. On the one hand, NO and RNS have been shown to acutely inhibit mitochondrial respiration and muscle contractile function [21], [25]-[27]; thus a scavenger of ROS-RNS [23] or NOS inhibitor [25] prevents muscle dysfunction. On the other hand, iNOS expression has been shown to increase dramatically in disease-resistant oxidative muscles following pathological challenges, and iNOS inhibition increases disease susceptibility [11]. Furthermore, chronic inhibition of NOS resulted in muscle dysfunction and atrophy [28]. In light of these apparently conflicting findings, the functional role of NO and its derivatives in skeletal muscle wasting remain to be determined. In particular, there has not been an attempt to define the functional relationship between ROS and NO in skeletal muscle under the catabolic condition.
###end p 6
###begin p 7
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li2">[12]</xref>
###xml 1145 1152 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
We have recently obtained comprehensive physiological, morphological, biochemical and gene expression evidence in a mouse model of chronic heart failure to indicate that oxidative myofibers are more resistant than glycolytic myofibers to chronic heart failure [12]. Consistently, there are significant differences between these myofibers in their atrophic response to cachetic stimuli, such as LPS and TNF-alpha. To improve our understanding of the mechanism(s) underlying the protection associated with oxidative phenotype, we designed this study to focus on fiber type-specific differences in ROS and NO and to determine if NO plays a functional role of muscle atrophic process related to cachexia. We obtained evidence that oxidative muscles had greater production of NO and expression of antioxidant genes, and endure lower oxidative burden than glycolytic muscles in response to cachectic stimuli. We then tested the hypothesis that up-regulation of antioxidant genes were dependent on NO, and thereby provided the protection from cachectic stimuli. This hypothesis was confirmed both in cultured muscle cells and in intact skeletal muscle in vivo. Results from this study provide potential mechanistic insights into the relatively greater resistance to cachexia associated with oxidative phenotype in skeletal muscle.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Endotoxin induces less ROS production and muscle-specific E3 ligase expression in mouse oxidative soleus muscle than in glycolytic white vastus lateralis muscle
###end title 9
###begin p 10
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li2">[12]</xref>
###xml 571 585 559 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g001">Fig. 1A and 1B</xref>
###xml 648 663 636 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 663 666 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Bodine1">[1]</xref>
###xml 668 671 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Gomes1">[3]</xref>
###xml 673 676 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Lecker1">[4]</xref>
###xml 735 749 723 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g001">Fig. 1C and 1D</xref>
###xml 785 790 773 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 858 872 846 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g001">Fig. 1C and 1E</xref>
###xml 943 947 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li2">[12]</xref>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 1178 1183 <span type="species:ncbi:10090">mouse</span>
Oxidative myofibers are resistant to cachectic stimuli induced by chronic heart failure and inflammatory cytokines [12]. One possible explanation is that systemic inflammation induces less oxidative stress in oxidative than in glycolytic myofibers. To test this hypothesis, we injected mice with endotoxin and measured protein carbonylation as an index of oxidative stress. LPS injection (12 hours) did not result significant changes in carbonylated proteins in soleus muscles, but resulted in a significant (approximately50%) increase in white vastus lateralis muscles (Fig. 1A and 1B). LPS induced greater expression of muscle-specific E3 ligase MAFbx/atrogin-1[1], [3], [4] in white vastus lateralis muscles than in soleus muscles (Fig. 1C and 1D). LPS also significantly increased MuRF1 expression in vastus lateralis muscles, but not in soleus muscles (Fig. 1C and 1E). These findings are completely consistent with our previous findings [12]. Thus, endotoxin challenge results in significantly less oxidative stress, hence less activation of the proteosome-dependant protein degradation, in oxidative than in glycolytic muscles. We have also observed similar changes in a mouse model of sepsis induced by S. aureas infection (unpublished results). Therefore, the fiber type-specific muscle atrophic response appears to be relevant to various cachectic conditions that can be recapitulated by endotoxin injection.
###end p 10
###begin title 11
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Endotoxin induces less oxidative stress and proteosome-dependent protein degradation in mouse oxidative than in glycolytic muscles.
###end title 11
###begin p 12
###xml 280 296 280 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbox/atrogin-1</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 672 673 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 738 753 730 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 758 763 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 785 788 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 862 877 854 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 882 887 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 987 988 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
Whole muscle homogenates and total RNA from oxidative soleus muscles (SO) and glycolytic white vastus lateralis muscles (WV) 12 hours after intraperitoneal (i.p.) injection of LPS (1 mg/kg body weight) were assayed for the carbonyl groups by immunoblot analysis (A and B) and for MAFbox/atrogin-1 and MuRF1 mRNA expression by semi-quantitative RT-PCR (C, D and E). A) Immunoblots show total protein carbonylation (top panel) after LPS or saline injection (Con) with alpha-tubulin (bottom panel) as loading reference. Each lane was loaded with 20 microg of proteins, and data were shown in triplicates; B) Quantification and comparison of protein carbonylation (n = 12; ** P<0.01); C) Gel images show semi-quantitative RT-PCR analysis for MAFbx/atrogin-1 and MuRF1 mRNA expression with 18S ribosomal RNA as control; and D) and E) Quantification and comparison of MAFbx/atrogin-1 and MuRF1 mRNA expression. The SO muscles from saline injected mice were set as reference (n = 6; ** and *** P<0.01 and 0.001, respectively).
###end p 12
###begin title 13
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Endotoxin induces greater NO production and iNOS expression in mouse oxidative soleus muscle than in glycolytic white vastus lateralis muscle
###end title 13
###begin p 14
###xml 499 506 487 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2A</xref>
###xml 599 617 587 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2B, 2C and 2F</xref>
###xml 728 734 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(nNos)</italic>
###xml 809 816 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2D</xref>
###xml 851 857 839 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(eNos)</italic>
###xml 1003 1010 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2E</xref>
To understand the possible functional role of NO-dependent signaling/gene regulation in fiber type specificity of muscle wasting, we assessed NO production in both soleus and white vastus lateralis muscles by measuring the stable NO product, nitrite. Nitrite concentration was not significantly different between these two muscles under basal conditions. However, LPS injection led to approximately100% increase in nitrite concentration in soleus muscles, but not in white vastus lateralis muscles (Fig. 2A). The increase in nitrite in soleus muscle was associated with an enhanced iNOS expression (Fig. 2B, 2C and 2F) with majority of protein confined to the periphery of oxidative myofibers. In contrast, neuronal NO synthase (nNos) expression was reduced in both soleus and white vastus lateralis muscles (Fig. 2D), whereas endothelial NO synthase (eNos) expression was low in white vastus lateralis muscles under basal conditions and was induced to a level comparable to that in the soleus muscles (Fig. 2E) following LPS injection. These findings suggest that oxidative myofibers have great inducibility in NO production, probably through induced expression of iNOS.
###end p 14
###begin title 15
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Endotoxin induces greater iNOS expression and NO production in mouse oxidative than in glycolytic muscles.
###end title 15
###begin p 16
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNos</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNos</italic>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNos</italic>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNos</italic>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNos</italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNos</italic>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
Whole muscle homogenates, total RNA and muscle sections from SO and WV after LPS or saline injection were assayed for nitrite (A), iNos, nNos and eNos mRNA expression by semi-quantitative RT-PCR (B,C, D and E), and iNOS protein expression by immunofluorescence (F). A) Quantification and comparison of nitrite concentration (n = 5-6; ** P<0.01); B) Gel images show levels of iNos, nNos and eNos mRNA expression with 18S ribosomal RNA as control; C), D) and E) Quantification and comparison of iNos, nNos and eNos mRNA expression. The SO muscles from saline injected mice were set as reference (n = 9; ** and *** P<0.01 and 0.001, respectively); and F) Immunofluorescence staining for iNOS protein after LPS or saline (Con) injections (12 hours), showing higher level of basal and induced expression of iNOS in SO vs. WV muscles.
###end p 16
###begin title 17
Endotoxin induces greater antioxidant gene expression in oxidative soleus muscle than in glycolytic white vastus lateralis muscle
###end title 17
###begin p 18
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1, Sod2</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 380 383 380 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 557 566 557 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#8211;E</xref>
###xml 380 383 <span type="species:ncbi:9685">Cat</span>
Our finding of less oxidative stress in soleus muscles than white vastus lateralis muscles following endotoxin challenge prompted us to determine if enhanced antioxidant gene expression contributes to the protection of oxidative myofibers. We performed semi-quantitative RT-PCR analysis for mRNA of the antioxidant genes: superoxide dismutases (Sod1, Sod2 and Sod3) and catalase (Cat). LPS injection resulted in significantly increased expression for all four antioxidant genes in soleus muscles with no or less increases in white vastus lateralis muscles (Fig. 3A-E). We have, therefore, obtained evidence for differentially enhanced antioxidant gene expression in oxidative vs. glycolytic myofibers that are likely intrinsic to the muscles.
###end p 18
###begin title 19
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Endotoxin induces greater antioxidant gene expression in mouse oxidative than in glycolytic muscles.
###end title 19
###begin p 20
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 176 188 176 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 307 319 307 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 185 188 <span type="species:ncbi:9685">Cat</span>
###xml 316 319 <span type="species:ncbi:9685">Cat</span>
Total RNA from SO and WV after LPS or saline (Con) injection were assayed for antioxidant gene expression by semi-quantitative RT-PCR. A) Gel images show levels of Sod1, Sod2, Sod3 and Cat mRNA expression with 18S ribosomal RNA as control; and B), C), D) and E) Quantification and comparison of Sod1, Sod2, Sod3 and Cat mRNA, respectively (n = 9; *, ** and *** P<0.05, 0.01 and 0.001, respectively).
###end p 20
###begin title 21
NO donor blocks TNF-alpha-induced muscle-specific E3 ligase expression and enhances iNOS and antioxidant gene expression in cultured muscle cells
###end title 21
###begin p 22
###xml 486 501 482 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 547 562 543 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 585 599 577 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4A and 4B</xref>
###xml 637 641 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 668 682 656 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4C and 4D</xref>
###xml 961 965 949 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 967 971 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 973 977 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 982 985 970 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 1043 1047 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 1052 1055 1036 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 1111 1121 1095 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4E&#8211;4I</xref>
###xml 1140 1144 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 1149 1152 1133 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 1476 1480 1460 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Wasserman1">[29]</xref>
###xml 1545 1549 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Zhang1">[30]</xref>
###xml 1682 1685 1666 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 982 985 <span type="species:ncbi:9685">Cat</span>
###xml 1052 1055 <span type="species:ncbi:9685">Cat</span>
###xml 1149 1152 <span type="species:ncbi:9685">Cat</span>
Our findings that there are greater increases in NO production and antioxidant gene expression in oxidative than glycolytic muscles in response to cachectic stimuli suggest a functional link between NO production and the antioxidant defense system. To test this hypothesis, we cultured mouse C2C12 myoblasts with TNF-alpha in the presence and absence of NO donor, diethylenetriamine NO (DETA-NO). DETA-NO resulted in a moderate, but significant, reduction in the basal level expression MAFbx/atrogin-1 mRNA and completely blocked the induction of MAFbx/atrogin-1 induced by TNF-alpha (Fig. 4A and 4B). DETA-NO enhanced TNF-alpha-induced iNos expression significantly (Fig. 4C and 4D). These findings indicate that NO is sufficient to reduce cytokine-induced activation of the proteosome-dependent catabolic pathway, which appears to be mediated by iNOS. To determine if NO induces antioxidant gene expression, we performed semi-quantitative RT-PCR analysis for Sod1, Sod2, Sod3 and Cat. DETA-NO increased the basal level and TNF-alpha-induced Sod3 and Cat expression, whereas Sod1 and Sod2 were not responsive (Fig. 4E-4I), suggesting that Sod3 and Cat play an important role in mitigating oxidative stress induced by cytokines in myocytes. To further confirm that these findings are due to NO-dependent transcriptional activation of the antioxidant genes, we transfected C2C12 myoblasts with the antioxidant response element (ARE) TATA-Inr luciferase reporter gene, pARE-Luc [29], and treated the myoblasts with or without DETA-NO for 24 hours [30]. The reporter gene expression was significantly stimulated by NO donor, suggesting that NO stimulates antioxidant genes through the cis-acting ARE DNA sequences.
###end p 22
###begin title 23
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 79 94 75 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
NO enhances iNos and antioxidant gene expression, and blocks TNF-alpha-induced MAFbx/atrogin-1 mRNA expression in cultured myoblasts.
###end title 23
###begin p 24
###xml 174 189 170 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 191 195 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 398 413 394 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 452 455 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 518 533 514 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 559 560 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 621 625 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 647 650 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 713 717 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 772 776 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 778 782 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 784 796 780 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 818 821 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 899 903 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 905 909 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 911 923 907 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 793 796 <span type="species:ncbi:9685">Cat</span>
###xml 920 923 <span type="species:ncbi:9685">Cat</span>
Total RNA from cultured C2C12 myoblasts following treatment with NO donor, DETA-NO (0.2 mM), for 24 hours in the presence or absence of TNF-alpha (10 ng/ml) were assayed for MAFbx/atrogin-1, iNos and antioxidant gene expression by semi-quantitative RT-PCR and total protein lysates from transfected C2C12 myoblasts were harvested and assayed for luciferase activities. A) Gel images show levels of MAFbx/atrogin-1 mRNA expression (in triplicates) with 18S ribosomal RNA as control; B) Quantification and comparison of MAFbx/atrogin-1 mRNA (n = 11; ** and *** P<0.01 and 0.001, respectively); C) Gel images show levels of iNos mRNA expression with 18S ribosomal RNA as control; D) Quantification and comparison of iNos mRNA (n = 6; ** P<0.01); E) Gel images show levels of Sod1, Sod2, Sod3 and Cat mRNA expression with 18S ribosomal RNA as control; F), G), H) and I) Quantification and comparison of Sod1, Sod2, Sod3 and Cat mRNA, respectively (n = 6; * and ** P<0.05 and 0.01, respectively); and J) pARE-Luc reporter gene activity in C2C12 myoblasts treated with or without DETA-NO for 24 hours (n = 6; * P<0.05).
###end p 24
###begin title 25
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
S-nitrosoglutathione (GSNO) blocks endotoxin-induced muscle-specific E3 ligase expression and enhances iNOS and antioxidant gene expression in skeletal muscle in vivo
###end title 25
###begin p 26
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 443 458 443 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 491 505 491 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g005">Fig. 5A and 5B</xref>
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 578 592 578 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g005">Fig. 5C and 5D</xref>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 815 819 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 824 827 824 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 891 895 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 971 981 971 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g005">Fig. 5E&#8211;5I</xref>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 824 827 <span type="species:ncbi:9685">Cat</span>
###xml 900 903 <span type="species:ncbi:9685">Cat</span>
The findings in cultured muscle cells motivated an in vivo study to confirm the functional role of NO in intact skeletal muscle. We injected the mice with the endogenous NO donor, GSNO (1 mg/kg, i.p.; 6 hours before and immediately before LPS injection) and performed semi-quantitative RT-PCR analysis in plantaris muscles (a muscle with a mixture of both oxidative type IIa and glycolytic type IId/x and IIb fibers). GSNO effectively blocked MAFbx/atrogin-1 mRNA expression induced by LPS (Fig. 5A and 5B) and promoted iNos mRNA expression both with and without LPS injection (Fig. 5C and 5D). Therefore, NO protects myofibers from endotoxin-induced oxidative stress and prevent activation of the proteosome-dependent catabolic pathway, possibly through induced expression of iNOS. RT-PCR analysis for Sod1, Sod2, Sod3 and Cat in plantaris muscles showed that GSNO resulted in increases in Sod3 and Cat, but not Sod1 and Sod2, expression with and without LPS injection (Fig. 5E-5I). These findings were entirely consistent with the findings in cultured myoblasts, suggesting the importance of SOD3 and CAT in NO-mediated protection against cachetic stimuli.
###end p 26
###begin title 27
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 75 90 75 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
GSNO enhances iNos and antioxidant gene expression, and blocks LPS-induced MAFbx/atrogin-1 mRNA expression in mouse plantaris muscles.
###end title 27
###begin p 28
###xml 137 152 137 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 256 271 256 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 376 391 376 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 673 685 673 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1</italic>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 804 816 804 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3 and Cat</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 682 685 <span type="species:ncbi:9685">Cat</span>
###xml 813 816 <span type="species:ncbi:9685">Cat</span>
Total RNA following NO donor GSNO injections (1 mg/kg, i.p. twice) in mice with LPS (1 mg/kg) or saline injection (Con) were assayed for MAFbx/atrogin-1, iNos and antioxidant enzyme mRNA expression by semi-quantitative RT-PCR. A) Gel images show levels of MAFbx/atrogin-1 mRNA expression (in triplicates) with 18S ribosomal RNA as control; B) Quantification and comparison of MAFbx/atrogin-1 mRNA (n = 11; ** and ***P<0.01 and 0.001, respectively); C) Gel images show levels of iNos mRNA expression with 18S ribosomal RNA as control; D) Quantification and comparison of iNos mRNA (n = 6; ** and *** P<0.01 and 0.001, respectively); E) Gel images show levels of Sod1, Sod2, Sod3 and Cat mRNA expression with 18S ribosomal RNA as control; and F), G), H) and I) Quantification and comparison of Sod1, Sod2, Sod3 and Cat mRNA, respectively (n = 6; * and ** P<0.05, and 0.01, respectively).
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The mechanisms underlying the protection of oxidative myofibers against cachexia have been unclear. The major findings of this study are: 1) Protein oxidation and degradative protein (muscle-specific E3 ubiquitin ligase) expression were lower in oxidative than in glycolytic muscles in response to cachectic stimuli; 2) iNOS expression, NO production and antioxidant gene expression were higher in oxidative muscles than in glycolytic muscles; and 3) NO donors enhanced iNOS and antioxidant gene expression and attenuated atrophic muscle responses both in vitro and in vivo. These findings together strongly suggest that NO-dependent up-regulation of the antioxidant genes, at least partly mediated by iNOS, protects oxidative myofibers against cachectic stimuli. The studies not only provide potential mechanistic insights into the functional protection in oxidative muscle fibers, but also suggest the therapeutic value of enhanced NO signaling to the treatment of muscle wasting.
###end p 30
###begin p 31
###xml 229 233 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li2">[12]</xref>
###xml 372 386 368 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g001">Fig. 1A and 1B</xref>
###xml 712 716 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Hollander1">[31]</xref>
###xml 718 722 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Ji1">[32]</xref>
###xml 827 831 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Anderson1">[33]</xref>
###xml 908 918 904 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#8211;3E</xref>
The fiber type-specific muscle wasting could be due to an intrinsic difference(s) in the oxidant/antioxidant system. We have recently shown that oxidative myofibers are protected from cachectic stimuli, such as LPS and TNF-alpha [12]. The finding in this study that endotoxin resulted in significantly less protein oxidation in oxidative muscle than in glycolytic muscle (Fig. 1A and 1B) is consistent with the notion that a more robust basal and/or inducible antioxidant system in oxidative myofibers prevents ROS from accumulating to a high level causing cellular damage. In fact, it has been shown that oxidative muscles have more robust expression and activity of antioxidant enzymes than glycolytic muscles [31], [32], and there is less mitochondrial superoxide production in oxidative myofibers than glycolytic myofibers [33]. Our findings of enhanced antioxidant gene expression in oxidative muscles (Fig. 3A-3E) suggest that an inducible antioxidant system provides additional protection against muscle catabolism. Elucidation of the mechanism responsible for such an inducible defense system will likely lead to the discovery of new drug target(s) for cachexia.
###end p 31
###begin p 32
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2A</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Boveris1">[21]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Nin1">[25]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Reid1">[27]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames1">[23]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Nin1">[25]</xref>
###xml 588 595 588 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
We also found that oxidative muscles produce more NO than glycolytic muscle and exhibit attenuated atrophic responses following endotoxin challenge (Fig. 2A), raising the possibility of a cause-effect relationship between NO and muscle protection. Paradoxically, it has been shown that NO and RNS inhibit mitochondrial respiration and muscle contractile function [21], [25]-[27], which could be prevented by ROS-RNS scavengers [23] or NOS inhibitors [25]. The interpretation was that iNOS mediated NO production was detrimental to muscle wasting. These previous findings were obtained in ex vivo experiments focusing on the acute effect of NO on muscle metabolic and contractile functions. Therefore, the mechanism(s) by which NO may protect against long-term muscle injury is currently not known. Our fiber type-specific analysis provides exciting new insight, suggesting induced NO production may play a protection against cachectic stimuli, rather than mediate muscle wasting.
###end p 32
###begin p 33
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames1">[23]</xref>
###xml 514 536 514 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2A, 2B, 2C and 2F</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNos</italic>
###xml 642 656 642 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2B and 2D</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Grozdanovic1">[34]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Chang1">[35]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Comtois1">[36]</xref>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNos</italic>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Comtois1">[36]</xref>
###xml 944 948 944 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNos</italic>
###xml 985 999 985 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g002">Fig. 2B and 2E</xref>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
NO production in skeletal muscle could involve nNOS (NOS1), iNOS (NOS2) and/or eNOS (NOS3) as they have been detected in skeletal muscles. A recent study showed that LPS injection resulted in increased NO production and changes in redox state in skeletal muscle, which were absent in iNos-/- mice [23], demonstrating the relevance of iNOS in muscle wasting. Here, we observed that induced iNOS expression was associated with increased NO production in oxidative muscle that was protected from endotoxin challenge (Fig. 2A, 2B, 2C and 2F). In contrast, endotoxin resulted in decreased nNos expression in both oxidative and glycolytic muscles (Fig. 2B and 2D). nNOS protein is specifically expressed in glycolytic myofibers as part of dystrophin glycoprotein complex [34] that maintains skeletal muscle contractile function [35], [36]; reduced nNos expression here is consistent with a general sarcolemmal injury [36]. On the other hand, induced eNos expression in glycolytic myofibers (Fig. 2B and 2E) does not reconcile with the protection in oxidative myofibers. Taken together, cachexia-induced NO production in skeletal muscle appears to be mediated through enhanced iNOS expression. The apparent feed-forward regulation of NO production may prove to be critical in amplifying the signals necessary for the protection associated with oxidative phenotype.
###end p 33
###begin p 34
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames1">[23]</xref>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames2">[37]</xref>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos<sup>&#8722;/&#8722;</sup></italic>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Escames1">[23]</xref>
###xml 528 531 528 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 524 531 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos<sup>&#8722;/&#8722;</sup></italic>
###xml 799 803 799 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Lowenstein1">[38]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Krolick1">[11]</xref>
###xml 1349 1353 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Krolick1">[11]</xref>
###xml 1375 1383 1375 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1388 1395 1388 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1656 1660 1656 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 1100 1103 <span type="species:ncbi:10116">rat</span>
Paradoxically, melatonin, a powerful scavenger of both ROS and RNS, abolished the increases in NO production and GSSG/GSH ratio in isolated mitochondria from skeletal muscles [23] and heart [37] in mice challenged with endotoxin; these increases were absent in iNos-/- mice. Our confined staining of oxidative myofibers of iNOS to the periphery is most consistent with mitochondrial localization of iNOS protein, which is in agreement with a recent finding [23]. The previous findings that cachetic responses were absent in iNos-/- mice were interpreted as evidence that iNOS was responsible for mitochondrial dysfunction and oxidative stress in muscles wasting. However, precaution should be taken regarding these findings with overall inhibition of iNOS since whole body genetic disruption of the iNos gene and application of iNOS inhibitor leads to loss of iNOS function not only in skeletal muscles, but also in macrophages, which is critical for the induction of sepsis [38]. On the other hand, a powerful protective function of iNOS in skeletal muscle are suggested in previous studies using a rat model of myasthenia gravis [11] caused by autoantibodies binding to and inhibiting the nicotinic acetylcholine receptors at the neuromuscular junctions. iNOS inhibitor converted disease-resistant soleus muscle to a disease-susceptible phenotype [11]. In this study, both in vitro and in vivo findings provide strong evidence support the protective function of NO in skeletal muscle in cachexia. Nevertheless, a formal confirmation of iNOS function in skeletal muscle awaits the generation of an animal model of skeletal muscle-specific knockout of the iNos gene.
###end p 34
###begin p 35
###xml 134 144 134 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g003">Fig. 3A&#8211;3E</xref>
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 431 438 431 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 553 559 553 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4</xref>
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g005">5</xref>
###xml 668 672 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 1010 1017 1010 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4J</xref>
###xml 677 680 <span type="species:ncbi:9685">Cat</span>
We observed significant enhanced antioxidant genes in oxidative soleus muscles, but not in glycolytic white vastus lateralis muscles (Fig. 3A-3E), a first demonstration of fiber type-specific induction of antioxidant genes in a whole animal model of muscle wasting. We then addressed the question whether enhanced NO production/signaling renders protection against cachetic stimuli induced by endotoxin/cytokine. Both in vitro and in vivo findings suggest that NO reduces atrophic responses and enhances antioxidant gene expression in skeletal muscles (Fig. 4 and 5). To our knowledge, this is the first demonstration of simultaneous, fiber type-specific induction of Sod3 and Cat. Based on these findings, we now conclude that oxidative myofibers possess an intact NO-dependent signaling and transcription system protecting the myofibers from oxidative stress by enhancing the antioxidant system. The finding of enhanced reporter gene activity in cultured muscle cells transfected with the ARE reporter gene (Fig. 4J) further supports this conclusion and provides more direct evidence of transcriptional control. Further research should focus on the link between the NO signal and the transcriptional factors in skeletal muscle that is responsible for the inducible defense system.
###end p 35
###begin p 36
###xml 103 117 103 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g004">Fig. 4C and 4D</xref>
###xml 122 136 122 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g005">Fig. 5C and 5D</xref>
It is worth noticing that NO donor was sufficient both in vitro and in vivo to induce iNOS expression (Fig. 4C and 4D and Fig. 5C and 5D), suggesting that both culture muscle cells and skeletal muscles have intact machineries to induce iNOS expression; the difference may be that oxidative muscle, but not glycolytic muscle, has the ability to trigger the initial increase in NO production. Future experiments should focus on elucidating the mechanism underlying this important regulatory event.
###end p 36
###begin p 37
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Kawano1">[39]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Davila1">[41]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Ockaili1">[42]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Das1">[43]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Salloum1">[44]</xref>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-ObasanjoBlackshire1">[45]</xref>
Accumulating evidence supports the view that NO and RNS play protective functions in various tissues/organs and disease models [39]-[41]. Perhaps, the most relevant findings are in the heart [42], [43] through an iNOS-dependent mechanism [44] as cardiac muscle has metabolic and contractile functions that more closely resemble oxidative skeletal muscles. More recently, a calcineurin/NFAT (nuclear factor of activated T-cells) signaling cascade has been implicated in cardiomyocyte protection through the transcriptional control of the iNos gene [45]. Ours is the first report that NO and RNS play a protective role against cachetic stimuli in skeletal muscle. We believe that NO elicits signaling events leading to the transcriptional activation of the antioxidant genes though the exact signaling and molecular mechanisms responsible for the up-regulation of the antioxidant genes remain to be elucidated.
###end p 37
###begin p 38
###xml 373 379 373 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002086-g006">Fig. 6</xref>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
In summary, findings from this study are consistent with a hypothesis as following. Cachexia leads to increased oxidative stress and consequently activation of protein degradation pathways in glycolytic myofibers. Enhanced iNOS expression and NO production lead to enhanced antioxidant gene expression in oxidative myofibers, providing protection against oxidative stress (Fig. 6). These findings suggest a therapeutic value of enhancing NO signaling in skeletal muscle for cachexia. Future investigations should ascertain the functional role of enhanced NO signaling in protection against various types of muscle atrophy and elucidate the molecular mechanism(s) responsible for the fiber type-specific expression of iNos and antioxidant genes. It should be noted that skeletal muscle wasting during cachexia could be affected by protein synthesis, protein degradation, autophagy and other processes. The finding of linking NO-dependent inducible antioxidant system to reduced atrogene expression may represent one of the mechanisms of endogenous defense systems in skeletal muscle under the condition of cachectic challenges.
###end p 38
###begin title 39
Schematic presentation of a novel framework for oxidative phenotype-associated protection against muscle wasting.
###end title 39
###begin p 40
Cachectic factors increase ROS in glycolytic myofibers; oxidative stress in turn results in up-regulation of atrophic genes (atrogenes), enhances protein degradation and muscle atrophy. ROS are reduced in oxidative myofibers due to expression of iNOS and NO-dependent up-regulation of the antioxidant genes, leading to less atrogene expression and protein degradation. Thick and thin arrows represent great and little increase/stimulation, respectively.
###end p 40
###begin title 41
Materials and Methods
###end title 41
###begin title 42
Experimental animals
###end title 42
###begin p 43
###xml 232 242 226 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 301 308 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 593 600 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 301 308 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Male C57BL/6 mice (8-9 weeks old) from the Jackson Laboratory (Bar Harbor, ME) were maintained in light- (12:12 h light-dark cycle) and temperature-controlled quarter (21degreesC) provided with water and chow (Purina, Richmond, IN) ad libitum. They were intraperitoneally injected (i.p. 1 mg/kg) with E. coli LPS (Sigma, St. Louis, MO) or normal saline 12 hours before being sacrificed by isoflurane-induced anesthesia and cervical dislocation. LPS injection did not result in morbidity or mortality. Soleus and white vastus lateralis muscles were harvested. To determine the role of NO donor in vivo, GSNO (Sigma, St. Louis, MO) were injected (i.p. 1 mg/kg) twice (6 hours prior to and at the time of LPS or normal saline injection). Plantaris muscles were harvested 12 hours later. All animal protocols were approved by the Duke University Institutional Animal Care and Use Committee.
###end p 43
###begin title 44
Protein carbonylation assay
###end title 44
###begin p 45
To determine the level of oxidative stress in skeletal muscle, carbonyl levels of proteins were determined in whole muscle lysates by using the OxyBlottrade mark Protein Oxidation Detection Kit (Serologicals Corporation, Norcross, GA). Briefly, harvested skeletal muscles were placed in 5-ml Falcon tubes each containing 1 ml of ice-cold Protein Lysis Buffer (Cell Signaling Technology, Danvers, MA) supplemented with 50 mM dithiothreitol (DDT) and 1 mM phenylmethylsulphonyl fluoride (PMSF) and homogenized with an Ultra Turrax T25 Polytrontrade mark homogenizer. The homogenates were centrifuged at 16,000 x g for 5 min at 4degreesC, and the supernatants were then transferred to 10K NMMWL-0.5 ml Ultrafree Filter Unit (Millipore, Bedford, MA) and centrifuged at 16,000 x g at 4degreesC (about 30 min) to concentrate to a volume of about 60 microl. Protein concentration was then determined by using the RC DC protein assay (BioRad, Hercules, CA). Protein carbonylation was then determined in the whole muscle lysate (20 microg protein) by an immunblot-based assay according to the instructions from the manufacturer. The intensities of all the bands in each of the lanes were quantified by using Scion Image (Scion Corporation, Frederick, Maryland) and normalized by alpha-tubulin.
###end p 45
###begin title 46
Nitrite assay
###end title 46
###begin p 47
Nitrite was assessed using the Griess Reagent System (Promega, Madison, WI). In brief, harvested skeletal muscles were homogenized immediately in ice-cold Protein Lysis Buffer (Cell Signaling Technology, Danvers, MA) containing 1 mM PMSF in a Wheaton glass-on-glass homogenizer on ice, and the homogenate was centrifuged at 16,000 x g for 5 min at 4degreesC. The protein concentration of the supernatants was determined as described above. The nitrite assay was started by adding the sample (360 microg proteins in 50 microl) to 50 microl sulfanilamide solutions in 96-well plates in duplicate. After incubation at room temperature for 10 min, 50 microl of the N-1-napthylethylenediamine dihydrochloride (NED) solution was added, and the reaction was continued for another 10 min. Absorbance at 550 nm was then measured, and nitrite concentration was calculated after normalization by total protein.
###end p 47
###begin title 48
Cell culture
###end title 48
###begin p 49
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
###xml 186 192 <span type="species:ncbi:9913">bovine</span>
C2C12 mouse myoblasts were grown and maintained as sub-confluent monolayer in high-glucose Dulbecco modified Eagle medium (DMEM; Gibco BRL, Grand Island, NY) supplemented with 20% fetal bovine serum (FBS, Gibco BRL, Grand Island, NY). To examine the effect of NO donor and iNOS inhibitor, C2C12 cells seeded in 35 mm-wells at 1 x 105 and allowed to adhere for at least 12 hour prior to stimulation by TNF-alpha (R&D Systems, Minneapolis, MN) at 10 ng/ml with/without DETA-NO (Sigma, St. Louis, MO). The cells were harvested 20 hours later, and total RNA samples were isolated for RT-PCR analysis by using Trizol (Invitrogen, Carlsbad, CA). For transfection of pARE-Luc, C2C12 myoblasts were transfected with 0.5 microg with Lipofectamine 2000 according the manufacturer's instructions. After overnight transfection, the transfected cells were treated with/without DETA-NO (10 ng/ml) for 24 hours. Luciferase activity was assayed and is expressed as relative activity (fold change) in comparison to the value of transfected cells without DETA-NO. The transfection was done twice with triplicate samples for each condition.
###end p 49
###begin title 50
Semi-quantitative RT-PCR
###end title 50
###begin p 51
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002086-Li2">[12]</xref>
###xml 57 72 57 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod-1</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod-2</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod-3</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Cat)</italic>
###xml 377 392 377 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAFbx/atrogin-1</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MuRF1</italic>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iNos</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS:</italic>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nNOS:</italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod1:</italic>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod2</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sod3</italic>
###xml 724 727 724 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cat</italic>
###xml 788 791 788 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 145 148 <span type="species:ncbi:9685">Cat</span>
###xml 724 727 <span type="species:ncbi:9685">Cat</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
This analysis was performed as described [12] to measure MAFbx/atrogin-1, MuRF1, iNos, superoxide dismutases (Sod-1, Sod-2, Sod-3) and catalase (Cat) mRNA expression in skeletal muscles and in cultured C2C12 myoblasts. PCR primer pairs were designed using Primer3 search engine at . The oligonuleotide primer pairs used in this study corresponded to the following nucleotides: MAFbx/atrogin-1: 1917-1936 and 2415-2396 (NM_026346); MuRF1: 50-69 and 452-433 (AF294790); iNos: 1815-1834 and 2301-2282 (MMU43428); eNOS: 1515-1534 and 2002-1983 (NM_008713); nNOS: 1261-1272 and 1735-1716 (NM_008712); Sod1: 168-187 and 583-564 (NM_011434); Sod2: 1218-1237 and 1647-1628 (BC066063); Sod3: 1547-1566 and 2019-2000 (NM_011435); and Cat: 237-256 and 645-626 (MMU43428). Results were normalized by 18S rRNA and presented as fold change to soleus muscle in mice injected with normal saline.
###end p 51
###begin title 52
Statistics
###end title 52
###begin p 53
###xml 217 218 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are presented as mean+/-standard error. For comparisons involving two factors, two-way ANOVA was performed followed by the Newman-Kuels test. For comparisons between two groups, the Student t-test was performed. P<0.05 was accepted as statistically significant for all the experiments in this study.
###end p 53
###begin p 54
We greatly appreciate Ms. Beverley Fermor for the excellent technical assistance in the nitrite assay.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
Identification of ubiquitin ligases required for skeletal muscle atrophy.
###end article-title 56
###begin article-title 57
###xml 61 65 <span type="species:ncbi:10090">mice</span>
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
###end article-title 57
###begin article-title 58
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.
###end article-title 58
###begin article-title 59
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.
###end article-title 59
###begin article-title 60
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
###end article-title 60
###begin article-title 61
Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes.
###end article-title 61
###begin article-title 62
Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.
###end article-title 62
###begin article-title 63
###xml 67 72 <span type="species:ncbi:9606">human</span>
Muscle in chronic uremia-a histochemical and morphometric study of human quadriceps muscle biopsies.
###end article-title 63
###begin article-title 64
[Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases].
###end article-title 64
###begin article-title 65
###xml 62 66 <span type="species:ncbi:10116">rats</span>
Skeletal Muscle wasting and contractile performance in septic rats.
###end article-title 65
###begin article-title 66
###xml 128 131 <span type="species:ncbi:10116">rat</span>
Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis.
###end article-title 66
###begin article-title 67
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.
###end article-title 67
###begin article-title 68
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
###end article-title 68
###begin article-title 69
Denervation-Induced Skeletal Muscle Atrophy is Associated with Increased Mitochondrial ROS Production.
###end article-title 69
###begin article-title 70
###xml 91 95 <span type="species:ncbi:10116">rats</span>
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats.
###end article-title 70
###begin article-title 71
###xml 61 64 <span type="species:ncbi:10116">rat</span>
Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: effects of pentoxifylline and somatostatin.
###end article-title 71
###begin article-title 72
Sepsis increases oxidatively damaged proteins in skeletal muscle.
###end article-title 72
###begin article-title 73
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle.
###end article-title 73
###begin article-title 74
###xml 142 145 <span type="species:ncbi:10116">rat</span>
Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat.
###end article-title 74
###begin article-title 75
Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy.
###end article-title 75
###begin article-title 76
The role of mitochondrial nitric oxide synthase in inflammation and septic shock.
###end article-title 76
###begin article-title 77
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure.
###end article-title 77
###begin article-title 78
###xml 133 137 <span type="species:ncbi:10090">mice</span>
Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice.
###end article-title 78
###begin article-title 79
###xml 65 73 <span type="species:ncbi:9606">patients</span>
NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight.
###end article-title 79
###begin article-title 80
Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.
###end article-title 80
###begin article-title 81
Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction.
###end article-title 81
###begin article-title 82
Nitric oxide modulates excitation-contraction coupling in the diaphragm.
###end article-title 82
###begin article-title 83
###xml 95 99 <span type="species:ncbi:10116">rats</span>
Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats.
###end article-title 83
###begin article-title 84
Functional antioxidant responsive elements.
###end article-title 84
###begin article-title 85
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
###end article-title 85
###begin article-title 86
Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training.
###end article-title 86
###begin article-title 87
Glutathione and antioxidant enzymes in skeletal muscle: effects of fiber type and exercise intensity.
###end article-title 87
###begin article-title 88
Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation.
###end article-title 88
###begin article-title 89
Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex.
###end article-title 89
###begin article-title 90
Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.
###end article-title 90
###begin article-title 91
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Lipopolysaccharide-induced diaphragmatic contractile dysfunction and sarcolemmal injury in mice lacking the neuronal nitric oxide synthase.
###end article-title 91
###begin article-title 92
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice.
###end article-title 92
###begin article-title 93
Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.
###end article-title 93
###begin article-title 94
iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite.
###end article-title 94
###begin article-title 95
Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha.
###end article-title 95
###begin article-title 96
Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.
###end article-title 96
###begin article-title 97
###xml 109 116 <span type="species:ncbi:9986">rabbits</span>
Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits.
###end article-title 97
###begin article-title 98
Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
###end article-title 98
###begin article-title 99
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
###end article-title 99
###begin article-title 100
Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase.
###end article-title 100
###begin p 101
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 101
###begin p 102
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study is supported by the American Heart Association-Mid-Atlantic Affiliate Post-doctoral Fellowship 0625518 (to P.L.), National Institutes of Health R01-HLO59130 (to J.S.S), and Grant-in-Aid 0555426U (to Z.Y.).
###end p 102

